首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Reviews in cardiovascular medicine

缩写:REV CARDIOVASC MED

ISSN:1530-6550

e-ISSN:2153-8174

IF/分区:1.3/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1878
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Shuantong Lin,Yulong Guan Shuantong Lin
Tricuspid regurgitation (TR) is a critical factor in the progression of right heart failure. Although conventional open surgery remains the definitive treatment, the application of this technique is significantly limited in older and high-r...
Mohammad Iqbal,Iwan Cahyo Santosa Putra,Giky Karwiky et al. Mohammad Iqbal et al.
Despite the relatively low incidence of Brugada syndrome (BrS) globally, the risk of sudden cardiac death remains alarmingly high, reaching rates of up to 28%. According to current clinical guidelines, implantable cardioverter defibrillator...
Itamar Loewenstein,Oren Yagel,Maayan Shrem et al. Itamar Loewenstein et al.
Background: Complete atrioventricular block (CAVB) following transcatheter aortic valve replacement (TAVR) is primarily attributed to mechanical compression of the penetrating or branching portions of the His bundle, and ...
Petroula Nana,George Apostolidis,José I Torrealba et al. Petroula Nana et al.
Background: Various anatomical factors have been related to mortality after endovascular aortic aneurysm repair (EVAR). This systematic review investigated the impact of the pre-operative maximum aortic aneurysm diameter ...
Xin Fan,Jie Ma,Xu Zhao et al. Xin Fan et al.
Heart failure with preserved ejection fraction (HFpEF) has progressively emerged as the predominant form of heart failure. Thus, studies on the underlying mechanisms of HFpEF have shifted from pathophysiological to molecular factors. Meanwh...
Mohammed Alaa Raslan,Hussein Abdul Nabi,Nour B Odeh et al. Mohammed Alaa Raslan et al.
Background: Transthyretin (TTR) cardiac amyloidosis is a progressive cardiomyopathy with high mortality; however, the role of implantable cardioverter-defibrillators (ICDs) in this population remains unclear. ...
Xiao-Lin Li,Zhen-Xun Wan,Hang Jiang et al. Xiao-Lin Li et al.
Heart failure (HF) represents a class of cardiovascular diseases that poses a serious threat to global health. Although current pharmacological and device-based therapies have exhibited some progress, significant challenges remain, includin...
Xinming Xu,Safraz Anwar,Yunpeng Shang et al. Xinming Xu et al.
Background: Gut microbiota are associated with heart failure (HF); however, the causal relationship between gut microbial communities and HF of varying etiologies remains incompletely established. ...
Huan Liu,Yongnan Lyu,Wen Dai et al. Huan Liu et al.
Background: Growth differentiation factor-15 (GDF-15) has emerged as a novel biomarker for coronary artery disease (CAD). Although the hypercoagulable state is recognized as a biological mechanism that triggers cardiac ev...
Karim Ali,Mohamed K Awad,Hussain Majeed et al. Karim Ali et al.
Cardiac amyloidosis (CA) represents an increasingly recognized but historically underdiagnosed cause of restrictive cardiomyopathy and heart failure. CA is now understood to be more prevalent, particularly in older adults, as advancements i...